Topics

FDA Approves Celgene and Acceleron's Treatment for Rare Blood Disease

19:00 EST 7 Nov 2019 | BioSpace

The approval marks the first approved treatment in the United States for this condition.

Original Article: FDA Approves Celgene and Acceleron's Treatment for Rare Blood Disease

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Celgene and Acceleron's Treatment for Rare Blood Disease"

Quick Search